Skip to content
10-K

Annual Report

THERALINK TECHNOLOGIES, INC.

0001493152-22-036824

← back to feed
Filed
Dec 29, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Dec 29, 2022 6.15B sh
Capex FY 2022 · Sep 30, 2021 $135.7K
Operating Cash Flow FY 2022 · Sep 30, 2021 −$4.78M
Current Liabilities FY 2022 · Sep 30, 2021 $3.3M
Total Liabilities FY 2022 · Sep 30, 2021 $3.58M
Current Assets FY 2022 · Sep 30, 2021 $638.75K
Total Assets FY 2022 · Sep 30, 2021 $1.64M
Eps Basic FY 2022 · Sep 30, 2021 $0.00
Net Income FY 2022 · Sep 30, 2021 −$5.47M
Operating Income FY 2022 · Sep 30, 2021 −$5.57M
Gross Profit FY 2022 · Sep 30, 2021 $388.15K
Cost Of Revenue FY 2022 · Sep 30, 2021 $117.46K
Revenue FY 2022 · Sep 30, 2021 $505.6K
Stockholders Equity FY 2022 · Sep 30, 2020 −$307.6K